A Molecular Psychiatry study identifies a toxic protein Death Switch driving Alzheimer’s progression, with potential to block it therapeutically.
Redox Biology study identifies PP4 protein in sepsis, helping control sepsis overreaction and guiding new treatments for sepsis.
*Molecular Pharmaceutics* study highlights Peptide technology enabling Oral insulin pills, offering an alternative to injections.
Blood Journal study shows inflammation drives bone loss in childhood leukaemia, including aggressive lymphoblastic leukaemia.
Moral injury in healthcare highlights deeper ethical conflict beyond burnout, with serious clinician wellbeing risks.
Study finds bariatric surgery improves obesity-related hypertension and metabolic dysfunction more than nonsurgical treatments.